| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
108,411 |
100,552 |
$88.14M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
134,482 |
129,698 |
$56.36M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
218,120 |
209,620 |
$50.56M |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
123,270 |
35,332 |
$14.24M |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
13,375 |
12,754 |
$13.33M |
| 70553 |
Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences |
6,767 |
6,446 |
$12.32M |
| 95810 |
Polysomnography; sleep staging with 4 or more additional parameters |
6,349 |
6,147 |
$11.03M |
| 44970 |
|
2,419 |
2,249 |
$9.97M |
| 95782 |
|
5,640 |
5,465 |
$9.83M |
| 97150 |
Therapeutic procedure(s), group (2 or more individuals) |
77,242 |
20,754 |
$7.52M |
| G0378 |
Hospital observation service, per hour |
18,670 |
9,184 |
$6.63M |
| 42820 |
Tonsillectomy and adenoidectomy; younger than age 12 |
4,947 |
4,858 |
$5.81M |
| 76770 |
|
14,902 |
14,156 |
$5.11M |
| 70450 |
Computed tomography, head or brain; without contrast material |
13,522 |
12,437 |
$5.09M |
| 95812 |
|
10,805 |
10,601 |
$5.02M |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
4,145 |
3,911 |
$4.86M |
| D9420 |
|
3,545 |
2,368 |
$4.78M |
| 70543 |
|
2,033 |
1,941 |
$4.08M |
| 73721 |
Magnetic resonance imaging, any joint of lower extremity; without contrast material |
3,044 |
2,826 |
$3.90M |
| 69436 |
Tympanostomy (requiring insertion of ventilating tube), general anesthesia |
7,073 |
6,904 |
$3.83M |
| 72197 |
|
1,851 |
1,775 |
$3.73M |
| 97161 |
|
19,196 |
18,314 |
$3.30M |
| 71046 |
Radiologic examination, chest; 2 views |
40,964 |
38,912 |
$3.29M |
| 99291 |
Critical care, evaluation and management of the critically ill patient, first 30-74 minutes |
2,607 |
2,414 |
$3.26M |
| 74183 |
|
1,656 |
1,584 |
$3.00M |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
28,077 |
9,500 |
$2.87M |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
3,184 |
2,970 |
$2.72M |
| 74230 |
|
5,154 |
4,981 |
$2.70M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
27,500 |
24,453 |
$2.65M |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
6,988 |
6,621 |
$2.65M |
| J3490 |
Unclassified drugs |
98,265 |
65,237 |
$2.62M |
| 93975 |
|
5,887 |
5,505 |
$2.35M |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
2,367 |
2,239 |
$2.20M |
| 92611 |
|
5,208 |
4,988 |
$2.20M |
| 42830 |
|
2,291 |
2,240 |
$2.15M |
| 97162 |
|
10,782 |
9,934 |
$2.09M |
| 96450 |
|
3,367 |
2,626 |
$2.07M |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
23,409 |
22,302 |
$2.06M |
| P9016 |
Red blood cells, leukocytes reduced, each unit |
2,619 |
2,230 |
$2.03M |
| 72141 |
|
1,836 |
1,737 |
$1.83M |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
21,148 |
20,321 |
$1.82M |
| 54161 |
|
1,740 |
1,707 |
$1.81M |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
12,435 |
4,358 |
$1.81M |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
35,895 |
14,571 |
$1.74M |
| V5261 |
Hearing aid, digital, binaural, bte |
919 |
703 |
$1.71M |
| J0586 |
Injection, abobotulinumtoxina, 5 units |
1,654 |
1,294 |
$1.67M |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
14,311 |
13,247 |
$1.64M |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
26,526 |
25,044 |
$1.62M |
| V5247 |
Hearing aid, digitally programmable analog, monaural, bte (behind the ear) |
1,671 |
778 |
$1.60M |
| 74019 |
|
21,613 |
20,392 |
$1.54M |
| 96409 |
|
7,139 |
4,676 |
$1.53M |
| 96361 |
Intravenous infusion, hydration; each additional hour |
26,357 |
22,954 |
$1.51M |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
17,555 |
15,839 |
$1.50M |
| 95819 |
|
3,364 |
3,280 |
$1.49M |
| 49452 |
|
1,132 |
1,025 |
$1.48M |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
4,378 |
1,954 |
$1.43M |
| 92523 |
|
4,682 |
4,478 |
$1.43M |
| 74455 |
|
2,926 |
2,850 |
$1.41M |
| 36430 |
|
3,159 |
2,463 |
$1.41M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
14,599 |
13,586 |
$1.38M |
| 76886 |
|
4,258 |
3,681 |
$1.35M |
| 70486 |
|
1,689 |
1,624 |
$1.32M |
| 76536 |
|
4,110 |
3,956 |
$1.31M |
| 54640 |
|
963 |
924 |
$1.30M |
| 74240 |
|
2,583 |
2,518 |
$1.29M |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
5,497 |
5,221 |
$1.29M |
| D2930 |
Prefabricated stainless steel crown - primary tooth |
2,572 |
2,472 |
$1.27M |
| 92526 |
|
9,454 |
4,537 |
$1.24M |
| 74018 |
|
11,569 |
10,609 |
$1.21M |
| D0230 |
Intraoral - periapical each additional radiographic image |
3,400 |
3,207 |
$1.20M |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
149,036 |
125,360 |
$1.19M |
| 72146 |
|
1,397 |
1,318 |
$1.18M |
| 80053 |
Comprehensive metabolic panel |
106,181 |
93,651 |
$1.17M |
| D0220 |
Intraoral - periapical first radiographic image |
3,591 |
3,382 |
$1.16M |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
7,872 |
7,411 |
$1.08M |
| 92652 |
|
1,392 |
1,329 |
$1.06M |
| J2704 |
Injection, propofol, 10 mg |
63,707 |
59,234 |
$1.06M |
| 51600 |
|
3,019 |
2,941 |
$1.05M |
| 92610 |
|
4,232 |
3,899 |
$1.04M |
| J0585 |
Injection, onabotulinumtoxina, 1 unit |
1,037 |
824 |
$1.01M |
| 92587 |
|
11,195 |
10,766 |
$978K |
| 45380 |
Colonoscopy, flexible; with biopsy, single or multiple |
770 |
733 |
$960K |
| 92567 |
|
15,924 |
15,248 |
$958K |
| 76870 |
|
4,176 |
3,945 |
$956K |
| 77072 |
|
8,129 |
7,939 |
$953K |
| 99215 |
Prolong outpt/office vis |
7,655 |
7,237 |
$934K |
| 70360 |
|
6,750 |
6,619 |
$911K |
| J0475 |
Injection, baclofen, 10 mg |
782 |
700 |
$889K |
| 70480 |
|
821 |
777 |
$884K |
| L1960 |
Ankle foot orthosis, posterior solid ankle, plastic, custom fabricated |
2,408 |
1,685 |
$861K |
| 84443 |
Thyroid stimulating hormone (TSH) |
39,647 |
38,389 |
$821K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
812 |
749 |
$816K |
| 86920 |
|
3,954 |
3,445 |
$804K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
23,273 |
22,458 |
$788K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
21,356 |
14,888 |
$745K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
16,735 |
6,604 |
$743K |
| 96411 |
|
3,246 |
1,759 |
$733K |
| 77075 |
|
1,896 |
1,767 |
$731K |
| 51701 |
|
15,036 |
14,308 |
$719K |
| 24538 |
|
547 |
528 |
$704K |
| 72081 |
|
4,052 |
3,943 |
$700K |
| 20680 |
|
269 |
260 |
$700K |
| 92579 |
|
7,502 |
7,347 |
$700K |
| 76506 |
|
1,930 |
1,834 |
$698K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
12,188 |
9,825 |
$668K |
| 95715 |
|
473 |
404 |
$664K |
| 72142 |
|
645 |
612 |
$650K |
| 92585 |
|
937 |
872 |
$636K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
11,570 |
10,970 |
$591K |
| 72147 |
|
599 |
568 |
$587K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
4,099 |
3,964 |
$569K |
| 97760 |
|
4,298 |
2,801 |
$567K |
| 93886 |
|
962 |
923 |
$564K |
| 92524 |
|
4,465 |
4,202 |
$553K |
| 72149 |
|
573 |
543 |
$548K |
| 70250 |
|
4,550 |
4,186 |
$537K |
| 95716 |
|
283 |
252 |
$528K |
| 97165 |
|
3,546 |
3,251 |
$527K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
14,102 |
13,887 |
$527K |
| D0274 |
Bitewings - four radiographic images |
1,179 |
1,149 |
$511K |
| 76641 |
|
1,317 |
1,248 |
$508K |
| S1040 |
Cranial remolding orthosis, pediatric, rigid, with soft interface material, custom fabricated, includes fitting and adjustment(s) |
273 |
259 |
$507K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
4,624 |
4,435 |
$489K |
| D7140 |
Extraction, erupted tooth or exposed root |
1,316 |
1,263 |
$468K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
16,734 |
15,338 |
$460K |
| 86003 |
|
3,173 |
3,111 |
$416K |
| D0272 |
Bitewings - two radiographic images |
1,833 |
1,698 |
$401K |
| 72170 |
|
4,586 |
4,418 |
$380K |
| 64642 |
|
1,192 |
1,129 |
$373K |
| 72040 |
|
3,413 |
3,227 |
$360K |
| P9040 |
Red blood cells, leukocytes reduced, irradiated, each unit |
594 |
487 |
$342K |
| 72100 |
|
2,904 |
2,805 |
$341K |
| 77080 |
|
1,332 |
1,245 |
$339K |
| 84439 |
|
30,463 |
29,404 |
$339K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
2,080 |
1,949 |
$333K |
| 95951 |
|
190 |
116 |
$327K |
| L1970 |
Ankle foot orthosis, plastic with ankle joint, custom fabricated |
649 |
456 |
$322K |
| 73610 |
|
4,684 |
4,465 |
$312K |
| 73630 |
|
4,355 |
4,135 |
$310K |
| 96367 |
|
3,495 |
2,929 |
$306K |
| 76881 |
|
2,065 |
1,941 |
$305K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
6,057 |
5,802 |
$300K |
| 97542 |
|
3,469 |
3,079 |
$290K |
| 97763 |
|
3,828 |
1,561 |
$283K |
| 73562 |
|
2,965 |
2,784 |
$283K |
| 87507 |
|
2,214 |
1,747 |
$283K |
| 92522 |
|
1,272 |
1,237 |
$274K |
| 72082 |
|
1,041 |
997 |
$274K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
5,321 |
4,964 |
$270K |
| 87581 |
|
21,138 |
20,317 |
$259K |
| 87486 |
|
21,131 |
20,310 |
$258K |
| 70544 |
|
400 |
358 |
$257K |
| V5264 |
Ear mold/insert, not disposable, any type |
6,795 |
3,558 |
$255K |
| 80061 |
Lipid panel |
15,812 |
15,331 |
$254K |
| 73590 |
|
3,981 |
3,626 |
$244K |
| 49446 |
|
168 |
145 |
$241K |
| 97166 |
|
1,325 |
1,175 |
$236K |
| 92508 |
Group treatment of speech, language, voice, communication, and/or auditory processing disorder |
1,800 |
226 |
$224K |
| 86140 |
|
48,883 |
44,084 |
$220K |
| 82728 |
|
13,393 |
12,496 |
$219K |
| 72156 |
|
119 |
116 |
$216K |
| 76800 |
|
551 |
510 |
$213K |
| 94660 |
|
896 |
540 |
$213K |
| 92582 |
|
2,422 |
2,358 |
$213K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
7,349 |
7,177 |
$208K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
27,559 |
26,942 |
$208K |
| 73090 |
|
5,810 |
5,446 |
$200K |
| D1351 |
Sealant - per tooth |
966 |
921 |
$199K |
| 94668 |
|
1,632 |
760 |
$197K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
2,288 |
2,217 |
$196K |
| D7111 |
|
972 |
919 |
$195K |
| 92512 |
|
2,502 |
2,339 |
$193K |
| 73130 |
|
2,824 |
2,685 |
$193K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
9,565 |
9,181 |
$191K |
| 71045 |
Radiologic examination, chest; single view |
3,091 |
2,804 |
$189K |
| 92555 |
|
3,220 |
3,124 |
$188K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
25,698 |
23,287 |
$187K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
7,195 |
6,542 |
$186K |
| D1120 |
Prophylaxis - child |
1,796 |
1,680 |
$185K |
| 73552 |
|
2,549 |
2,274 |
$185K |
| 84403 |
|
5,203 |
5,002 |
$181K |
| 25605 |
|
803 |
765 |
$177K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
50,985 |
47,512 |
$173K |
| 95700 |
|
1,471 |
1,344 |
$172K |
| 43246 |
|
219 |
196 |
$171K |
| 88304 |
|
5,286 |
5,052 |
$171K |
| 73720 |
|
82 |
80 |
$169K |
| 83970 |
|
3,282 |
3,162 |
$167K |
| 72070 |
|
1,563 |
1,506 |
$167K |
| 82670 |
|
4,540 |
4,375 |
$165K |
| 31622 |
|
342 |
315 |
$162K |
| 92604 |
|
1,523 |
1,207 |
$161K |
| D0240 |
|
528 |
487 |
$160K |
| 82784 |
|
10,073 |
9,627 |
$160K |
| 86160 |
|
5,088 |
4,872 |
$159K |
| 92557 |
|
1,009 |
981 |
$159K |
| 86850 |
|
7,192 |
6,129 |
$157K |
| 73560 |
|
1,696 |
1,530 |
$156K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
13,198 |
12,844 |
$155K |
| 73070 |
|
3,344 |
3,066 |
$155K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
1,609 |
1,459 |
$154K |
| 87040 |
|
20,420 |
18,924 |
$151K |
| 49500 |
|
91 |
91 |
$150K |
| 84305 |
|
5,394 |
5,261 |
$148K |
| 12011 |
|
2,521 |
2,452 |
$147K |
| L1907 |
Ankle orthosis, supramalleolar with straps, with or without interface/pads, custom fabricated |
404 |
240 |
$146K |
| 86480 |
|
1,786 |
1,761 |
$146K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
907 |
783 |
$143K |
| 99205 |
Prolong outpt/office vis |
815 |
778 |
$141K |
| 82570 |
|
19,617 |
18,558 |
$139K |
| 86235 |
|
1,144 |
1,082 |
$138K |
| 85246 |
|
4,631 |
4,429 |
$138K |
| 83002 |
|
5,788 |
5,546 |
$138K |
| 72157 |
|
90 |
82 |
$134K |
| 83498 |
|
3,573 |
3,514 |
$133K |
| 78708 |
|
148 |
144 |
$133K |
| 87799 |
|
1,127 |
916 |
$129K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
20,806 |
19,648 |
$127K |
| 73110 |
|
1,322 |
1,251 |
$127K |
| 64643 |
|
635 |
566 |
$126K |
| 73140 |
|
2,372 |
2,281 |
$126K |
| 86922 |
|
499 |
427 |
$126K |
| 69210 |
|
661 |
648 |
$125K |
| 92552 |
|
1,941 |
1,861 |
$124K |
| 92602 |
|
995 |
773 |
$122K |
| 72158 |
|
66 |
66 |
$122K |
| 83001 |
|
4,985 |
4,775 |
$119K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
3,668 |
3,286 |
$114K |
| 94644 |
|
6,224 |
5,909 |
$113K |
| 93971 |
|
377 |
359 |
$112K |
| S0080 |
Injection, pentamidine isethionate, 300 mg |
1,481 |
1,221 |
$111K |
| 69610 |
|
157 |
155 |
$110K |
| 10061 |
|
681 |
649 |
$109K |
| 95816 |
|
296 |
290 |
$108K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
50,319 |
44,208 |
$106K |
| 70491 |
|
141 |
135 |
$103K |
| 42821 |
|
76 |
76 |
$103K |
| 85045 |
|
23,161 |
19,356 |
$103K |
| 76010 |
|
1,830 |
1,768 |
$100K |
| 43762 |
|
652 |
588 |
$95K |
| 71250 |
|
101 |
95 |
$95K |
| 86360 |
|
1,599 |
1,526 |
$92K |
| 97164 |
|
855 |
746 |
$91K |
| 62270 |
|
550 |
485 |
$90K |
| 82627 |
|
2,975 |
2,911 |
$90K |
| 87070 |
|
9,644 |
9,104 |
$87K |
| 87077 |
|
9,632 |
9,132 |
$86K |
| 12001 |
|
1,645 |
1,604 |
$86K |
| 14040 |
|
57 |
57 |
$85K |
| 80069 |
|
7,977 |
7,316 |
$82K |
| 83516 |
|
5,186 |
4,836 |
$82K |
| V5257 |
Hearing aid, digital, monaural, bte |
94 |
69 |
$81K |
| J0330 |
Injection, succinylcholine chloride, up to 20 mg |
2,510 |
2,270 |
$80K |
| 54163 |
|
85 |
83 |
$80K |
| 86901 |
|
7,604 |
6,469 |
$79K |
| 82785 |
|
3,597 |
3,514 |
$78K |
| 94642 |
|
992 |
885 |
$78K |
| 87081 |
|
7,991 |
7,595 |
$77K |
| APT15 |
|
7,326 |
5,790 |
$76K |
| 83550 |
|
7,190 |
6,971 |
$76K |
| 92556 |
|
1,602 |
1,546 |
$76K |
| 85652 |
|
24,885 |
23,499 |
$75K |
| 81001 |
|
31,567 |
29,726 |
$75K |
| 83735 |
|
10,670 |
8,476 |
$75K |
| 76376 |
|
556 |
543 |
$74K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
119 |
105 |
$74K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
5,251 |
4,760 |
$73K |
| 85027 |
|
9,719 |
9,047 |
$73K |
| 76885 |
|
280 |
227 |
$73K |
| 92593 |
|
625 |
539 |
$72K |
| 85730 |
|
9,480 |
8,784 |
$72K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
32,326 |
29,082 |
$72K |
| 86317 |
|
1,727 |
946 |
$71K |
| 84402 |
|
2,044 |
1,984 |
$71K |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
1,795 |
1,620 |
$71K |
| 97750 |
|
450 |
430 |
$70K |
| 86376 |
|
3,629 |
3,533 |
$70K |
| 88342 |
|
1,216 |
1,146 |
$70K |
| 84146 |
|
2,721 |
2,651 |
$69K |
| P9011 |
Blood, split unit |
213 |
197 |
$68K |
| 82043 |
|
8,805 |
8,508 |
$67K |
| D2392 |
Resin-based composite - two surfaces, posterior, primary or permanent |
461 |
432 |
$66K |
| J9370 |
Vincristine sulfate, 1 mg |
6,764 |
4,491 |
$66K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
2,931 |
2,657 |
$66K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
48,055 |
44,082 |
$66K |
| 73030 |
|
1,084 |
1,011 |
$65K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
33,896 |
27,826 |
$63K |
| 81003 |
|
36,502 |
34,547 |
$62K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
16,353 |
13,780 |
$62K |
| 86256 |
|
3,754 |
3,623 |
$62K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
3,170 |
2,961 |
$61K |
| 74241 |
|
149 |
141 |
$60K |
| 83690 |
|
12,302 |
11,379 |
$59K |
| 83540 |
|
7,402 |
7,172 |
$58K |
| 87186 |
|
7,373 |
6,958 |
$58K |
| 73060 |
|
1,069 |
1,022 |
$57K |
| D2391 |
Resin-based composite - one surface, posterior, primary or permanent |
539 |
495 |
$56K |
| 82977 |
|
10,918 |
10,229 |
$55K |
| 86800 |
|
2,629 |
2,564 |
$55K |
| L2280 |
Addition to lower extremity, molded inner boot |
180 |
120 |
$55K |
| 99244 |
Office or other outpatient consultation, moderate to high complexity |
245 |
241 |
$55K |
| 89230 |
|
631 |
614 |
$54K |
| 92586 |
|
608 |
551 |
$54K |
| J1569 |
Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg |
76 |
41 |
$54K |
| J2795 |
Injection, ropivacaine hydrochloride, 1 mg |
2,343 |
2,262 |
$54K |
| 82803 |
|
9,278 |
8,576 |
$53K |
| 49650 |
|
14 |
12 |
$53K |
| 85240 |
|
2,320 |
2,201 |
$53K |
| 86147 |
|
739 |
721 |
$52K |
| 86039 |
|
3,633 |
3,484 |
$52K |
| 85610 |
|
10,974 |
9,827 |
$52K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
3,113 |
2,956 |
$51K |
| 85245 |
|
1,746 |
1,673 |
$51K |
| 86146 |
|
763 |
720 |
$51K |
| 82397 |
|
2,623 |
2,572 |
$50K |
| 82533 |
|
2,087 |
1,958 |
$50K |
| 49591 |
|
27 |
24 |
$50K |
| 86357 |
|
1,603 |
1,527 |
$49K |
| 86355 |
|
1,583 |
1,517 |
$49K |
| 84480 |
|
2,807 |
2,713 |
$48K |
| 96415 |
|
259 |
136 |
$47K |
| 73000 |
|
907 |
852 |
$46K |
| 73080 |
|
478 |
447 |
$46K |
| 86359 |
|
1,781 |
1,528 |
$46K |
| 97163 |
|
168 |
143 |
$46K |
| 88185 |
|
146 |
126 |
$45K |
| 84156 |
|
9,404 |
8,719 |
$45K |
| 31720 |
|
428 |
299 |
$45K |
| 82157 |
|
1,247 |
1,196 |
$45K |
| 81025 |
|
11,862 |
11,174 |
$43K |
| J0690 |
Injection, cefazolin sodium, 500 mg |
18,916 |
15,008 |
$43K |
| D2330 |
|
541 |
531 |
$43K |
| 95811 |
|
26 |
24 |
$43K |
| 76942 |
|
385 |
339 |
$42K |
| 51702 |
|
277 |
251 |
$42K |
| J9035 |
Injection, bevacizumab, 10 mg |
38 |
12 |
$42K |
| 85397 |
|
1,480 |
1,428 |
$42K |
| 86341 |
|
1,118 |
983 |
$41K |
| 97116 |
|
644 |
412 |
$41K |
| V5266 |
Battery for use in hearing device |
8,063 |
4,431 |
$40K |
| 95885 |
|
160 |
155 |
$40K |
| 82607 |
|
2,064 |
1,999 |
$39K |
| 99292 |
|
131 |
107 |
$39K |
| 82105 |
|
1,913 |
1,753 |
$39K |
| A9562 |
Technetium tc-99m mertiatide, diagnostic, per study dose, up to 15 millicuries |
181 |
176 |
$39K |
| 85384 |
|
3,887 |
3,547 |
$38K |
| 10060 |
|
311 |
297 |
$38K |
| 83880 |
|
1,421 |
1,309 |
$38K |
| 82330 |
|
9,965 |
9,205 |
$38K |
| 25565 |
|
165 |
154 |
$37K |
| 86364 |
|
3,269 |
3,232 |
$37K |
| 83520 |
|
1,748 |
1,574 |
$36K |
| 92609 |
|
702 |
407 |
$36K |
| 85999 |
|
1,705 |
1,622 |
$35K |
| 83020 |
|
5,002 |
4,304 |
$35K |
| J2710 |
Injection, neostigmine methylsulfate, up to 0.5 mg |
5,572 |
4,406 |
$35K |
| 84100 |
|
11,620 |
9,420 |
$35K |
| 49505 |
|
12 |
12 |
$34K |
| 73221 |
|
24 |
24 |
$34K |
| 72131 |
|
43 |
37 |
$33K |
| J2780 |
Injection, ranitidine hydrochloride, 25 mg |
1,055 |
440 |
$33K |
| 82150 |
|
6,712 |
6,156 |
$32K |
| 72128 |
|
28 |
26 |
$32K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
1,593 |
1,540 |
$31K |
| 82610 |
|
1,788 |
1,616 |
$31K |
| J0136 |
Injection, acetaminophen (b braun), not therapeutically equivalent to j0131, 10 mg |
1,193 |
1,130 |
$30K |
| 86902 |
|
2,490 |
2,097 |
$30K |
| L2840 |
Addition to lower extremity orthosis, tibial length sock, fracture or equal, each |
631 |
516 |
$30K |
| 80164 |
|
2,294 |
2,168 |
$30K |
| 92595 |
|
1,246 |
1,206 |
$30K |
| 80076 |
|
3,464 |
3,180 |
$29K |
| J0694 |
Injection, cefoxitin sodium, 1 gm |
3,351 |
2,173 |
$29K |
| 82248 |
|
6,643 |
5,614 |
$29K |
| 82565 |
|
1,644 |
1,581 |
$29K |
| 84145 |
|
3,275 |
3,119 |
$28K |
| 80197 |
|
1,674 |
1,342 |
$28K |
| 29105 |
|
735 |
707 |
$28K |
| APT16 |
|
2,142 |
1,719 |
$28K |
| 82550 |
|
5,907 |
5,521 |
$28K |
| 84436 |
|
4,171 |
3,979 |
$27K |
| 86900 |
|
7,606 |
6,470 |
$27K |
| 85576 |
|
524 |
495 |
$27K |
| 94060 |
|
206 |
183 |
$27K |
| 73100 |
|
825 |
749 |
$27K |
| J0561 |
Injection, penicillin g benzathine, 100,000 units |
417 |
412 |
$26K |
| S0164 |
Injection, pantoprazole sodium, 40 mg |
1,649 |
951 |
$26K |
| 97113 |
|
277 |
92 |
$26K |
| 62369 |
|
83 |
68 |
$25K |
| 82746 |
|
1,359 |
1,314 |
$25K |
| 83615 |
|
5,264 |
4,853 |
$25K |
| 94010 |
|
449 |
399 |
$25K |
| D2934 |
|
200 |
187 |
$24K |
| 70481 |
|
38 |
38 |
$24K |
| 74220 |
|
50 |
50 |
$24K |
| 95712 |
|
48 |
44 |
$24K |
| 92700 |
|
211 |
205 |
$23K |
| 85660 |
|
2,935 |
2,101 |
$23K |
| 85379 |
|
2,430 |
2,187 |
$23K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
9,305 |
6,718 |
$23K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
4,284 |
4,021 |
$23K |
| 86665 |
|
657 |
631 |
$23K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
47,577 |
43,068 |
$22K |
| L3203 |
Orthopedic shoe, oxford with supinator or pronator, junior |
356 |
247 |
$22K |
| 85520 |
|
1,308 |
1,211 |
$22K |
| 36590 |
|
27 |
27 |
$22K |
| 87045 |
|
705 |
673 |
$22K |
| 90686 |
|
4,415 |
4,023 |
$21K |
| 82024 |
|
425 |
414 |
$21K |
| 96376 |
|
874 |
758 |
$20K |
| S0030 |
Injection, metronidazole, 500 mg |
1,037 |
585 |
$19K |
| S0020 |
Injection, bupivicaine hydrochloride, 30 ml |
7,060 |
6,678 |
$19K |
| 84446 |
|
1,052 |
1,034 |
$19K |
| 94645 |
|
1,218 |
1,142 |
$19K |
| L2200 |
Addition to lower extremity, limited ankle motion, each joint |
550 |
401 |
$18K |
| 84703 |
|
3,488 |
3,278 |
$18K |
| S0077 |
Injection, clindamycin phosphate, 300 mg |
4,870 |
2,373 |
$18K |
| 80143 |
|
2,777 |
2,592 |
$18K |
| J0171 |
Injection, adrenalin, epinephrine, 0.1 mg |
2,199 |
2,092 |
$18K |
| 92607 |
|
127 |
101 |
$18K |
| 73660 |
|
295 |
283 |
$18K |
| 94726 |
|
150 |
136 |
$17K |
| L2820 |
Addition to lower extremity orthosis, soft interface for molded plastic, below knee section |
259 |
205 |
$17K |
| J9260 |
Injection, methotrexate sodium, 50 mg |
3,732 |
2,357 |
$17K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
163 |
151 |
$17K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
667 |
527 |
$16K |
| 95953 |
|
22 |
14 |
$16K |
| 82657 |
|
1,607 |
1,246 |
$16K |
| L3202 |
Orthopedic shoe, oxford with supinator or pronator, child |
350 |
204 |
$16K |
| 86337 |
|
544 |
539 |
$16K |
| 87205 |
|
5,823 |
5,392 |
$15K |
| 80179 |
|
2,637 |
2,490 |
$15K |
| 31526 |
|
13 |
13 |
$15K |
| 87116 |
|
315 |
290 |
$15K |
| 85670 |
|
1,907 |
1,831 |
$14K |
| 92650 |
|
190 |
160 |
$14K |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
12,020 |
11,325 |
$14K |
| 31624 |
|
14 |
12 |
$14K |
| 25600 |
|
256 |
246 |
$14K |
| 23350 |
|
13 |
12 |
$13K |
| 84460 |
|
1,963 |
1,883 |
$13K |
| L1930 |
Ankle foot orthosis, plastic or other material, prefabricated, includes fitting and adjustment |
97 |
57 |
$13K |
| 82340 |
|
1,851 |
1,785 |
$13K |
| 74270 |
|
24 |
24 |
$13K |
| J9070 |
Cyclophosphamide, 100 mg |
55 |
38 |
$13K |
| 84450 |
|
1,903 |
1,828 |
$13K |
| 92622 |
|
86 |
85 |
$13K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
801 |
771 |
$13K |
| 94667 |
|
700 |
545 |
$13K |
| APT17 |
|
924 |
883 |
$13K |
| J0295 |
Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm |
3,251 |
1,049 |
$13K |
| 82104 |
|
623 |
613 |
$13K |
| 87075 |
|
1,094 |
1,019 |
$12K |
| 86706 |
|
1,040 |
1,008 |
$12K |
| 88184 |
|
196 |
166 |
$12K |
| 82103 |
|
667 |
653 |
$12K |
| 84484 |
|
1,404 |
1,289 |
$12K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
146 |
112 |
$12K |
| 95713 |
|
41 |
36 |
$12K |
| 82077 |
|
2,312 |
2,196 |
$12K |
| 93325 |
|
127 |
123 |
$12K |
| 99243 |
|
66 |
65 |
$12K |
| 84590 |
|
818 |
802 |
$12K |
| 95813 |
|
29 |
24 |
$12K |
| 87340 |
|
1,006 |
979 |
$12K |
| 82390 |
|
787 |
768 |
$12K |
| J1170 |
Injection, hydromorphone, up to 4 mg |
3,416 |
3,121 |
$11K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
284 |
272 |
$10K |
| 86225 |
|
584 |
549 |
$10K |
| 80183 |
|
780 |
748 |
$10K |
| 82247 |
|
2,959 |
2,243 |
$10K |
| 86664 |
|
665 |
648 |
$10K |
| 85613 |
|
723 |
702 |
$10K |
| J1815 |
Injection, insulin, per 5 units |
418 |
388 |
$10K |
| 88307 |
|
127 |
125 |
$10K |
| 87206 |
|
1,030 |
963 |
$10K |
| 95908 |
|
39 |
39 |
$10K |
| 89051 |
|
4,075 |
3,298 |
$10K |
| 86769 |
|
252 |
238 |
$9K |
| 88108 |
|
352 |
290 |
$9K |
| J1953 |
Injection, levetiracetam, 10 mg |
471 |
406 |
$9K |
| 93000 |
|
298 |
289 |
$9K |
| D1206 |
Topical application of fluoride varnish |
375 |
340 |
$9K |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
1,965 |
1,897 |
$8K |
| 86663 |
|
646 |
630 |
$8K |
| 82947 |
|
11,354 |
10,666 |
$8K |
| 94729 |
|
70 |
67 |
$8K |
| 30460 |
|
25 |
25 |
$8K |
| 87015 |
|
1,583 |
1,481 |
$8K |
| 12002 |
|
349 |
342 |
$8K |
| 82085 |
|
532 |
523 |
$7K |
| 94664 |
|
831 |
798 |
$7K |
| 29065 |
|
274 |
264 |
$7K |
| 97010 |
|
42 |
30 |
$7K |
| 87102 |
|
607 |
569 |
$7K |
| 82948 |
|
4,013 |
2,141 |
$7K |
| D1208 |
Topical application of fluoride, excluding varnish |
573 |
524 |
$7K |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
1,713 |
1,466 |
$7K |
| 84244 |
|
230 |
227 |
$7K |
| 43247 |
|
13 |
13 |
$7K |
| 83525 |
|
379 |
356 |
$7K |
| S0028 |
Injection, famotidine, 20 mg |
1,198 |
670 |
$7K |
| 80195 |
|
381 |
311 |
$7K |
| D2332 |
|
72 |
69 |
$6K |
| 88312 |
|
134 |
120 |
$6K |
| J7042 |
5% dextrose/normal saline (500 ml = 1 unit) |
3,264 |
2,485 |
$6K |
| 82140 |
|
515 |
471 |
$6K |
| 84295 |
|
8,499 |
7,929 |
$6K |
| 69424 |
|
13 |
13 |
$6K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
60 |
54 |
$6K |
| 85014 |
|
8,896 |
8,238 |
$5K |
| 82310 |
|
1,645 |
1,463 |
$5K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
338 |
165 |
$5K |
| J2272 |
Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg |
744 |
694 |
$5K |
| J2060 |
Injection, lorazepam, 2 mg |
1,067 |
757 |
$5K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
50 |
50 |
$5K |
| 84550 |
|
1,540 |
1,390 |
$5K |
| 88341 |
|
41 |
41 |
$5K |
| 86880 |
|
756 |
716 |
$5K |
| 99170 |
|
55 |
54 |
$5K |
| 83718 |
|
484 |
468 |
$5K |
| J1596 |
Injection, glycopyrrolate, 0.1 mg |
830 |
798 |
$5K |
| J9255 |
Injection, methotrexate (accord), not therapeutically equivalent to j9260, 50 mg |
385 |
237 |
$5K |
| 24640 |
|
110 |
107 |
$5K |
| J7999 |
Compounded drug, not otherwise classified |
2,646 |
2,468 |
$5K |
| 96160 |
|
946 |
562 |
$5K |
| 80074 |
|
90 |
86 |
$5K |
| J1836 |
Injection, metronidazole, 10 mg |
453 |
347 |
$5K |
| S5571 |
Insulin delivery device, disposable pen (including insulin); 3 ml size |
222 |
216 |
$4K |
| J0290 |
Injection, ampicillin sodium, 500 mg |
1,984 |
1,191 |
$4K |
| 99233 |
Prolong inpt eval add15 m |
60 |
29 |
$4K |
| 43760 |
|
30 |
28 |
$4K |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
2,930 |
2,581 |
$4K |
| 86308 |
|
1,236 |
1,194 |
$4K |
| 82438 |
|
630 |
614 |
$4K |
| 83655 |
|
395 |
387 |
$4K |
| 87899 |
|
425 |
214 |
$4K |
| 77076 |
|
14 |
14 |
$4K |
| 85732 |
|
259 |
237 |
$4K |
| 29505 |
|
101 |
92 |
$4K |
| 86803 |
|
369 |
362 |
$4K |
| 84132 |
|
8,210 |
7,740 |
$4K |
| 90620 |
|
82 |
69 |
$4K |
| 29125 |
|
135 |
130 |
$4K |
| J9100 |
Injection, cytarabine, 100 mg |
313 |
200 |
$4K |
| 92588 |
|
28 |
27 |
$4K |
| J7070 |
Infusion, d5w, 1000 cc |
1,001 |
472 |
$4K |
| 86431 |
|
490 |
472 |
$4K |
| 92594 |
|
140 |
137 |
$4K |
| 87493 |
|
52 |
39 |
$4K |
| L3010 |
Foot, insert, removable, molded to patient model, longitudinal arch support, each |
66 |
38 |
$4K |
| D3220 |
Therapeutic pulpotomy (excluding final restoration) - removal of pulp coronal to the dentinocemental junction |
37 |
37 |
$4K |
| 90732 |
|
75 |
66 |
$3K |
| J1720 |
Injection, hydrocortisone sodium succinate, up to 100 mg |
241 |
184 |
$3K |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
4,139 |
3,281 |
$3K |
| C1713 |
Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) |
97 |
94 |
$3K |
| 82652 |
|
68 |
67 |
$3K |
| 94375 |
|
88 |
86 |
$3K |
| 82379 |
|
162 |
153 |
$3K |
| 86356 |
|
32 |
31 |
$3K |
| 87517 |
|
53 |
50 |
$3K |
| D2390 |
|
24 |
24 |
$3K |
| 88311 |
|
225 |
208 |
$3K |
| 90734 |
|
100 |
85 |
$3K |
| 84157 |
|
692 |
632 |
$3K |
| 82945 |
|
694 |
634 |
$3K |
| 87497 |
|
61 |
55 |
$3K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
205 |
188 |
$3K |
| 29075 |
|
25 |
25 |
$3K |
| 99245 |
|
14 |
13 |
$3K |
| 96523 |
|
86 |
83 |
$3K |
| 86812 |
|
132 |
130 |
$3K |
| 87046 |
|
706 |
674 |
$3K |
| J0692 |
Injection, cefepime hydrochloride, 500 mg |
190 |
135 |
$3K |
| 87522 |
Neg quan hep c or qual rna |
41 |
41 |
$3K |
| 82542 |
|
280 |
240 |
$2K |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
112 |
38 |
$2K |
| 86592 |
|
690 |
665 |
$2K |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
370 |
331 |
$2K |
| 82985 |
|
123 |
121 |
$2K |
| 80177 |
|
203 |
189 |
$2K |
| 73040 |
|
13 |
12 |
$2K |
| S5553 |
Insulin, long acting; 5 units |
169 |
151 |
$2K |
| 84445 |
|
193 |
190 |
$2K |
| 24530 |
|
13 |
12 |
$2K |
| 90461 |
|
87 |
51 |
$2K |
| J7050 |
Infusion, normal saline solution, 250 cc |
2,746 |
2,033 |
$2K |
| J7121 |
5% dextrose in lactated ringers infusion, up to 1000 cc |
123 |
79 |
$2K |
| 83605 |
|
149 |
144 |
$2K |
| 96127 |
|
538 |
329 |
$2K |
| 89050 |
|
416 |
378 |
$2K |
| 88313 |
|
33 |
25 |
$2K |
| S5551 |
Insulin, most rapid onset (lispro or aspart); 5 units |
173 |
151 |
$2K |
| 94760 |
|
1,093 |
589 |
$2K |
| 84702 |
|
212 |
205 |
$2K |
| 86611 |
|
53 |
50 |
$2K |
| L1210 |
Addition to tlso, (low profile), lateral thoracic extension |
12 |
12 |
$2K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
16 |
16 |
$2K |
| 16020 |
|
12 |
12 |
$2K |
| APT02 |
|
287 |
233 |
$2K |
| 0071A |
|
77 |
71 |
$2K |
| 84681 |
|
83 |
78 |
$2K |
| APT04 |
|
193 |
178 |
$2K |
| L4396 |
Static or dynamic ankle foot orthosis, including soft interface material, adjustable for fit, for positioning, may be used for minimal ambulation, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise |
13 |
12 |
$2K |
| 12051 |
|
18 |
17 |
$2K |
| J2430 |
Injection, pamidronate disodium, per 30 mg |
79 |
78 |
$2K |
| 72072 |
|
13 |
13 |
$2K |
| 80175 |
|
118 |
114 |
$2K |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
283 |
258 |
$2K |
| 80220 |
|
76 |
73 |
$2K |
| 82523 |
|
79 |
77 |
$2K |
| J0736 |
Injection, clindamycin phosphate, 300 mg |
213 |
103 |
$2K |
| 93304 |
|
14 |
13 |
$1K |
| J2543 |
Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) |
258 |
164 |
$1K |
| J1956 |
Injection, levofloxacin, 250 mg |
127 |
99 |
$1K |
| 86999 |
|
125 |
95 |
$1K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
27 |
14 |
$1K |
| 26720 |
|
14 |
13 |
$1K |
| 96368 |
|
143 |
139 |
$1K |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
22 |
14 |
$1K |
| 84478 |
|
574 |
437 |
$1K |
| 86200 |
|
65 |
65 |
$1K |
| L0984 |
Protective body sock, prefabricated, off-the-shelf, each |
15 |
15 |
$1K |
| 81403 |
|
16 |
12 |
$1K |
| L1830 |
Knee orthosis, immobilizer, canvas longitudinal, prefabricated, off-the-shelf |
12 |
12 |
$1K |
| 90834 |
Psychotherapy, 45 minutes with patient |
13 |
13 |
$1K |
| 83993 |
|
42 |
39 |
$1K |
| J7060 |
5% dextrose/water (500 ml = 1 unit) |
291 |
116 |
$1K |
| 82010 |
|
123 |
118 |
$1K |
| 85044 |
|
202 |
178 |
$1K |
| 23500 |
|
25 |
25 |
$976.43 |
| 30300 |
|
52 |
52 |
$973.53 |
| J3480 |
Injection, potassium chloride, per 2 meq |
445 |
263 |
$941.55 |
| 76857 |
|
14 |
14 |
$936.74 |
| D0120 |
Periodic oral evaluation - established patient |
48 |
48 |
$911.04 |
| 86684 |
|
42 |
41 |
$900.49 |
| 0124A |
|
36 |
27 |
$865.42 |
| 82239 |
|
38 |
38 |
$862.76 |
| APT09 |
|
70 |
52 |
$833.70 |
| J3489 |
Injection, zoledronic acid, 1 mg |
91 |
87 |
$831.61 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
20 |
16 |
$792.27 |
| 82139 |
|
47 |
42 |
$775.72 |
| 90715 |
|
68 |
67 |
$770.82 |
| J1940 |
Injection, furosemide, up to 20 mg |
984 |
950 |
$763.07 |
| 0001A |
|
33 |
31 |
$753.84 |
| 93321 |
|
17 |
16 |
$752.80 |
| 12032 |
|
12 |
12 |
$742.94 |
| 80339 |
|
45 |
38 |
$724.94 |
| J9000 |
Injection, doxorubicin hydrochloride, 10 mg |
66 |
38 |
$699.87 |
| J9360 |
Injection, vinblastine sulfate, 1 mg |
36 |
12 |
$698.92 |
| L1240 |
Addition to tlso, (low profile), lumbar derotation pad |
13 |
13 |
$694.75 |
| 87147 |
|
251 |
236 |
$677.34 |
| 0072A |
|
27 |
24 |
$671.60 |
| 81015 |
|
183 |
177 |
$618.76 |
| 84134 |
|
37 |
28 |
$583.15 |
| J1171 |
Injection, hydromorphone, 0.1 mg |
132 |
130 |
$574.85 |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
58 |
54 |
$511.19 |
| 0053A |
|
18 |
18 |
$509.26 |
| J0461 |
Injection, atropine sulfate, 0.01 mg |
221 |
181 |
$504.58 |
| 86645 |
|
25 |
25 |
$496.08 |
| 87807 |
|
30 |
30 |
$489.82 |
| 82017 |
|
37 |
30 |
$479.08 |
| 84207 |
|
15 |
14 |
$452.17 |
| 95873 |
|
33 |
30 |
$426.00 |
| APT18 |
|
29 |
27 |
$408.80 |
| 0003A |
|
19 |
19 |
$403.77 |
| 86644 |
|
26 |
26 |
$388.77 |
| 87430 |
|
26 |
25 |
$385.36 |
| 80180 |
|
53 |
52 |
$366.72 |
| 82270 |
|
105 |
94 |
$347.75 |
| 87529 |
|
12 |
12 |
$331.25 |
| 90656 |
|
120 |
120 |
$328.83 |
| 84425 |
|
13 |
12 |
$320.52 |
| 90685 |
|
67 |
64 |
$299.52 |
| 85018 |
|
143 |
136 |
$285.27 |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
26 |
25 |
$283.69 |
| 83519 |
|
13 |
12 |
$272.43 |
| 83921 |
|
14 |
13 |
$269.77 |
| 84432 |
|
13 |
12 |
$269.58 |
| J1453 |
Injection, fosaprepitant, 1 mg |
20 |
16 |
$266.02 |
| 83918 |
|
13 |
12 |
$261.86 |
| 86255 |
|
20 |
16 |
$260.11 |
| 83150 |
|
13 |
12 |
$253.08 |
| 82950 |
|
41 |
38 |
$237.45 |
| 99053 |
|
10,020 |
9,876 |
$231.00 |
| 12013 |
|
73 |
67 |
$228.89 |
| 84630 |
|
18 |
17 |
$226.63 |
| 84210 |
|
13 |
13 |
$223.00 |
| J2470 |
Injection, pantoprazole sodium, 40 mg |
37 |
25 |
$212.15 |
| 87185 |
|
40 |
40 |
$208.68 |
| 84075 |
|
54 |
53 |
$207.88 |
| 82525 |
|
13 |
13 |
$197.41 |
| 84585 |
|
13 |
12 |
$192.86 |
| J3360 |
Injection, diazepam, up to 5 mg |
14 |
12 |
$191.45 |
| 96161 |
|
102 |
46 |
$178.37 |
| 82465 |
|
41 |
40 |
$164.40 |
| APT08 |
|
12 |
12 |
$139.20 |
| 80299 |
|
46 |
46 |
$138.13 |
| 70355 |
|
12 |
12 |
$137.76 |
| 87184 |
|
13 |
13 |
$111.28 |
| 83721 |
|
12 |
12 |
$110.52 |
| 85046 |
|
13 |
12 |
$99.85 |
| J2920 |
Injection, methylprednisolone sodium succinate, up to 40 mg |
18 |
14 |
$84.06 |
| 92551 |
|
42 |
24 |
$58.32 |
| 84030 |
|
12 |
12 |
$41.08 |
| 99173 |
|
92 |
84 |
$23.60 |
| 3078F |
|
553 |
402 |
$2.83 |
| 3074F |
|
463 |
321 |
$2.11 |
| 1126F |
|
190 |
165 |
$0.97 |
| 1125F |
|
133 |
112 |
$0.79 |
| 3008F |
|
1,099 |
812 |
$0.02 |
| 92608 |
|
85 |
76 |
$0.00 |
| 2001F |
|
535 |
445 |
$0.00 |
| V5008 |
Hearing screening |
63 |
60 |
$0.00 |
| 2010F |
|
534 |
444 |
$0.00 |
| 90723 |
|
14 |
12 |
$0.00 |
| 0001F |
|
260 |
232 |
$0.00 |
| 2000F |
|
105 |
92 |
$0.00 |
| 1036F |
|
104 |
94 |
$0.00 |
| D4355 |
|
13 |
13 |
$0.00 |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
17 |
14 |
$0.00 |
| 36415 |
Collection of venous blood by venipuncture |
44 |
41 |
$0.00 |
| 36416 |
|
29 |
28 |
$0.00 |
| 3725F |
|
38 |
32 |
$0.00 |
| 1160F |
|
320 |
217 |
$0.00 |
| G8483 |
Influenza immunization was not administered for reasons documented by clinician (e.g., patient allergy or other medical reasons, patient declined or other patient reasons, vaccine not available or other system reasons) |
288 |
247 |
$0.00 |
| 90670 |
|
31 |
27 |
$0.00 |
| 90648 |
|
31 |
27 |
$0.00 |
| 86008 |
|
58 |
58 |
$0.00 |
| 1159F |
|
235 |
147 |
$0.00 |
| 1033F |
|
189 |
171 |
$0.00 |
| 90633 |
|
13 |
13 |
$0.00 |